Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.

13-07-2023

Dr Albert L. Kraus

Advisory Board Member 
Expert in in regulatory sciences and global medicine development
14-11-2022

Dr Chantal Van Gils

Advisory Board Director 
Expert in in real-world research, epidemiology and health economics.
01-10-2020

Dr Isabel Schemainda

Principal Consultant
Expert in EU and US regulatory procedures & stratergies
20-10-2022

Dr Jan Sjöberg

Medical Advisor and Advisory Board Member 
Expert in haematology and internal medicine.
01-10-2020

Dr Kurt Stoeckli

Scientific Advisor
Expert in biopharmaceutical R&D strategy and operational management
01-10-2020

Dr Laurie Smaldone Alsup

SVP Regulatory Science
Expert in clinical development and regulatory strategy
19-10-2022

Dr Mads Hansen

Advisory Board Member 
Expert in Hematology and oncology
01-10-2020

Dr Mary Teeling

Advisory Board Member
Expert in clinical development and market authorisation applications

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.